ROLLER Raises US$50 Million to Fuel AI‑Driven Leap in Attractions Tech

In a strategic move that underscores both ambition and momentum, ROLLER (roller.software) — the cloud‑based venue management platform serving leisure and attractions operators across 30+ countries — has secured a fresh injection of US $50 million to accelerate innovation and global reach. The funding round is led by existing backer Insight Partners, which previously led the company’s US $50 million raise…

Read More

Supper Raises $11M to Simplify Enterprise Data Access, Accelerating Decision-Making

Supper, the AI-driven data platform designed to streamline enterprise data access, has raised $11 million in a seed funding round led by Union Square Ventures, with participation from BoxGroup, Inspired Capital, Torch Capital, and Avid Ventures. The round aims to accelerate Supper’s mission of enabling fast, reliable, and secure insights across high-growth organizations. Founded by…

Read More

HavocAI Secures $11 Million Seed Funding to Transform Autonomous Vessel Operations

In a significant leap toward revolutionizing the maritime technology landscape, HavocAI Inc., an innovator in autonomous uncrewed surface vessel (USV) technology, has successfully closed an $11 million Seed funding round. This financing was led by Scout Ventures and co-led by Trousdale Ventures, with participation from a distinguished roster of investors including Outlander VC, The Veteran…

Read More

LTZ Therapeutics Secures $20M Series A to Revolutionize Cancer Treatment with Cutting-Edge Myeloid Engager Technology

LTZ Therapeutics, an emerging leader in immunotherapy, has successfully completed a $20 million Series A financing round. This round, spearheaded by new investor Lapam Capital and including significant contributions from GL Ventures, K2 Venture Partners, and Shunwei Capital, brings LTZ’s total funding to approximately $50 million since its inception in 2022. The new capital will…

Read More

Hyro Raises $45 M to Cement AI Agents as the New Frontline in Healthcare Access

Hyro, a conversational‑AI platform built for healthcare enterprises, has announced a $45 million strategic growth funding round led by Healthier Capital, with participation from Norwest, Define Ventures, and strategic investors including Bon Secours Mercy Health and ServiceNow Ventures. The financing comes just ten months after Hyro’s previous raise and brings its total funding to approximately $95 million. Co‑founded by…

Read More

Solidroad Secures $1.2M Investment to Expand AI-Powered Enterprise SaaS Platform

Dublin-based Solidroad has successfully raised $1.2 million in a recent funding round aimed at bolstering its AI-driven enterprise software solutions for hiring, onboarding, and training. The investment, led by prominent figures including Dan Kiely, Jack Pierce, Ciaran Lee, Anne Heraty, and Louise Phelan, underscores confidence in Solidroad’s transformative technology and its potential to revolutionize workforce…

Read More

JPalmer Collective Secures $72 Million to Fuel Inclusive Financing and Accelerate Growth

In a pivotal move for inclusive financing, JPalmer Collective (JPC), an asset-based lending firm committed to supporting high-growth, women-led, and natural products companies, has successfully raised $72 million in gross proceeds. This substantial capital infusion is set to enhance JPC’s growth trajectory and facilitate new loans for its carefully selected clientele. The capital raise comprised…

Read More

LearnLaunch Fund + Accelerator Unveils 2024 Cohort, Investing in Edtech Innovators

In a decisive move to bolster the future of education through innovation, LearnLaunch Fund + Accelerator has introduced its prestigious 2024 Breakthrough to Scale program cohort. This initiative highlights five groundbreaking startups poised to redefine learning experiences worldwide with cutting-edge technology and human-centered design principles. Based in Boston, LearnLaunch Fund + Accelerator has solidified its…

Read More

Beacon Therapeutics Raises $170 Million to Propel Ophthalmic Gene Therapy Innovations

Beacon Therapeutics, a pioneering ophthalmic gene therapy company dedicated to combating blinding retinal diseases, has secured $170 million in Series B funding, marking a significant stride towards advancing its transformative treatments. Led by Forbion and supported by existing investors Syncona and Oxford Science Enterprises, alongside newcomers TCGX and Advent Life Sciences, this funding round will…

Read More